Invention Grant
- Patent Title: PD-1 antibodies
-
Application No.: US16064727Application Date: 2016-10-15
-
Publication No.: US10597454B2Publication Date: 2020-03-24
- Inventor: Andy Tsun , Cheng Chen , Xiaolin Liu , De-Chao Michael Yu
- Applicant: INNOVENT BIOLOGICS (SUZHOU) CO., LTD
- Applicant Address: CN Suzhou
- Assignee: INNOVENT BIOLOGICS (SUZHOU) CO., LTD
- Current Assignee: INNOVENT BIOLOGICS (SUZHOU) CO., LTD
- Current Assignee Address: CN Suzhou
- Agency: Ladas & Parry LLP
- International Application: PCT/CN2016/102238 WO 20161015
- International Announcement: WO2018/068336 WO 20180419
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61P35/00 ; A61K39/395 ; A61K38/16

Abstract:
The present invention provides antibodies that bind human programmed cell death 1 (PD-1), and may be useful for treating cancer alone and in combination with chemotherapy and other cancer therapeutics.
Public/Granted literature
- US20190023792A1 PD-1 ANTIBODIES Public/Granted day:2019-01-24
Information query